Integrating data from meningioma xenografts and patients, our results establish meningioma ADC as a potential non-invasive imaging biomarker of Wnt signaling in Merlin-intact meningiomas with S13 phosphorylation and favorable clinical outcomes (Fig. 4g). The gene discussed is NF2; the disease is meningioma.